title: Symptomatic liver involvement in neonatal hereditary hemorrhagic telangiectasia.
abstract: High-flow hepatic vascular anomalies with arteriovenous shunting commonly manifest during the neonatal period with signs and symptoms of congestive heart failure, but to our knowledge, they have never been described in patients with hereditary hemorrhagic telangiectasia (HHT). We report here our experience with 3 patients with hepatic arteriovenous malformations (AVMs) who presented with symptoms of high-output congestive heart failure during the neonatal period and were subsequently diagnosed with HHT. Imaging showed large hypervascular lesions and multiple hepatic arteriovenous shunts that differentiated these lesions from liver hemangiomas. Transcatheter embolization was performed in all cases. One infant died of sepsis shortly after embolization; follow-up at the age of 2.5 years of the surviving infants revealed involution of the vascular lesions and no evidence of symptom recurrence. We conclude that severe symptoms related to hepatic AVMs in HHT can occur in the neonatal period and that HHT should therefore be included in the differential diagnosis of symptomatic neonatal hepatic vascular malformations. Imaging plays a key role in differentiating hepatic AVMs from hemangiomas, because the latter require additional pharmacologic treatments. Early transcatheter embolization seems to be effective, but long-term outcomes still need to be assessed.
authors.affiliation: University of Toronto, Toronto, Ontario, Canada.
authors.forename: Suhail
authors.initials: S
authors.lastname: Al-Saleh
authors.forename: Philip R
authors.initials: PR
authors.lastname: John
authors.forename: Michelle
authors.initials: M
authors.lastname: Letarte
authors.forename: Marie E
authors.initials: ME
authors.lastname: Faughnan
authors.forename: Jaques
authors.initials: J
authors.lastname: Belik
authors.forename: Felix
authors.initials: F
authors.lastname: Ratjen
mesh_terms: D000792:Angiography; D003937:Diagnosis, Differential; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D008099:Liver / Q000098:blood supply* / Q000000981:diagnostic imaging; D008107:Liver Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D008297:Male; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications*; D014463:Ultrasonography; D054079:Vascular Malformations / Q000150:complications* / Q000175:diagnosis / Q000628:therapy